Cara Sauder1, Mara Kapsner-Smith1, Carolyn Baylor1,2, Kathryn Yorkston1,2, Neal Futran3, Tanya Eadie1,3. 1. Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA. 2. Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA. 3. Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVE: To determine how communicative participation is affected in patients with oral and oropharyngeal head and neck cancers (HNCs) pretreatment and whether communication function predicts HNC-specific quality of life (QOL) before treatment, beyond known demographic, medical, psychosocial, and swallowing predictors. STUDY DESIGN: Cross-sectional study. SETTING: Tertiary care academic medical center. METHODS: Eighty-seven patients with primary oral (40.2%) or oropharyngeal (59.8%) HNC were recruited prior to treatment. T stage, tumor site, and p16 status were extracted from medical records. Demographic and patient-reported measures were obtained. Communicative participation was measured using the Communicative Participation Item Bank (CPIB) General short form. A hierarchical regression analysis included demographic, medical, psychosocial, and functional measures of swallowing and communication as predictors; the University of Washington Quality of Life (UW-QOL v4) composite score was the predicted variable. RESULTS: Median (SD) baseline CPIB scores were 71.0 (11.83); patients with oral cancers reported worse scores. A final sequential hierarchical regression model that included all variables explained 71% of variance in QOL scores. Tumor site, T stage, and p16 status accounted for 28% of variance (P < .001). Perceived depression predicted an additional 28% of the variance (P < .001). Swallowing and communicative participation together predicted an additional 12% of variance (P = .005). Tumor site, perceived depression, swallowing, and communication measures were unique predictors in the final model. Finally, communicative participation uniquely predicted QOL, above and beyond other predictors. CONCLUSION: Pretreatment communication predicted QOL and was negatively affected in some oral and oropharyngeal patients with HNC.
OBJECTIVE: To determine how communicative participation is affected in patients with oral and oropharyngeal head and neck cancers (HNCs) pretreatment and whether communication function predicts HNC-specific quality of life (QOL) before treatment, beyond known demographic, medical, psychosocial, and swallowing predictors. STUDY DESIGN: Cross-sectional study. SETTING: Tertiary care academic medical center. METHODS: Eighty-seven patients with primary oral (40.2%) or oropharyngeal (59.8%) HNC were recruited prior to treatment. T stage, tumor site, and p16 status were extracted from medical records. Demographic and patient-reported measures were obtained. Communicative participation was measured using the Communicative Participation Item Bank (CPIB) General short form. A hierarchical regression analysis included demographic, medical, psychosocial, and functional measures of swallowing and communication as predictors; the University of Washington Quality of Life (UW-QOL v4) composite score was the predicted variable. RESULTS: Median (SD) baseline CPIB scores were 71.0 (11.83); patients with oral cancers reported worse scores. A final sequential hierarchical regression model that included all variables explained 71% of variance in QOL scores. Tumor site, T stage, and p16 status accounted for 28% of variance (P < .001). Perceived depression predicted an additional 28% of the variance (P < .001). Swallowing and communicative participation together predicted an additional 12% of variance (P = .005). Tumor site, perceived depression, swallowing, and communication measures were unique predictors in the final model. Finally, communicative participation uniquely predicted QOL, above and beyond other predictors. CONCLUSION: Pretreatment communication predicted QOL and was negatively affected in some oral and oropharyngeal patients with HNC.
Entities:
Keywords:
cancer outcomes; communication disorders; head and neck cancer; quality of life
Authors: Raghav C Dwivedi; Suzanne St Rose; Edward J Chisholm; Brian Bisase; Furrat Amen; Christopher M Nutting; Peter M Clarke; Cyrus J Kerawala; Peter H Rhys-Evans; Kevin J Harrington; Rehan Kazi Journal: Oral Oncol Date: 2012-01-29 Impact factor: 5.337
Authors: B M R Op de Coul; A H Ackerstaff; C J van As; F J A van den Hoogen; C A Meeuwis; J J Manni; F J M Hilgers Journal: Clin Otolaryngol Date: 2005-04 Impact factor: 2.597
Authors: M Bryant Howren; Alan J Christensen; Lucy Hynds Karnell; Julia R Van Liew; Gerry F Funk Journal: Head Neck Date: 2012-06-19 Impact factor: 3.147
Authors: Jason Y K Chan; Lannah L Lua; Heather H Starmer; Daniel Q Sun; Elizabeth S Rosenblatt; Christine G Gourin Journal: Laryngoscope Date: 2011-05-03 Impact factor: 3.325
Authors: Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah Journal: Int J Radiat Oncol Biol Phys Date: 2005-03-01 Impact factor: 7.038
Authors: Katherine A Hutcheson; Martha P Barrow; Asher Lisec; Denise A Barringer; Kacie Gries; Jan S Lewin Journal: Laryngoscope Date: 2015-11-06 Impact factor: 3.325
Authors: Anders Näsman; Stefan Holzhauser; Ourania N Kostopoulou; Mark Zupancic; Andreas Ährlund-Richter; Juan Du; Tina Dalianis Journal: Viruses Date: 2021-05-14 Impact factor: 5.048